Sight Sciences, Inc.

Sight Sciences, Inc. is a medical technology company founded in 2011, focused on developing innovative interventional technologies for treating ophthalmologic conditions, particularly glaucoma and ocular surface disease, including dry eye disease. The company aims to enhance eyecare standards by creating less invasive and intuitive solutions that address the root causes of chronic eye diseases, enabling earlier intervention and improved patient outcomes. Headquartered in the United States, Sight Sciences has grown from a startup to a leader in interventional ophthalmology. The company emphasizes a science-first approach and clinical excellence, partnering with providers to develop procedural technologies that help maintain vision. Its product offerings include the TearCare® System for dry eye treatment, the OMNI® Surgical System for minimally invasive glaucoma surgery, and the CYCLOPS® Imaging System for glaucoma management. These products are supported by comprehensive training and resources for eye care professionals to promote global adoption.